Live from the NIH registry
Studies recruiting near Lakeland right now
Top 25 of 196 recruiting studies, sorted by proximity — each links to its official registry page
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Lakeland, Florida (1.2 mi)
· Sponsor: GlaxoSmithKline
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
Lakeland Regional Health Hollis Cancer Center — Lakeland, Florida (1.2 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Lakeland Regional Health Hollis Cancer Center — Lakeland, Florida (1.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
Sinonasal Squamous Cell Carcinoma, Stage III Sinonasal Cancer AJCC v8
Phase 2
Interventional 108 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Winter Haven Hospital — Winter Haven, Florida (13.7 mi)
· Sponsor: Novo Nordisk A/S
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Plasma Cell Myeloma Refractory
Phase 2
Interventional 64 participants sought
The Oncology Institute of Hope & Innovation - Lakeland- Site Number : 8400054 — Lakeland, Florida (1.2 mi)
· Sponsor: Sanofi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Depressive Disorder, Major
Phase 3
Interventional 752 participants sought
Clinical Research of Brandon — Brandon, Florida (21.8 mi)
· Sponsor: Janssen Research & Development, LLC
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: SWOG Cancer Research Network
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Gout
Phase 2
Interventional 90 participants sought
Clinical Research of Central Florida — Lakeland, Florida (1.2 mi)
· Sponsor: Crystalys Therapeutics
A Trial to See if Daridorexant Can Help Adults and Elderly People With Insomnia Sleep Better During the Night and Function Better During the Day
Insomia Disorder
Phase 3
Interventional 344 participants sought
Teradan Clinical Trials, LLC — Brandon, Florida (21.8 mi)
· Sponsor: Idorsia Pharmaceuticals Ltd.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: SWOG Cancer Research Network
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
The Oncology Institute — Lakeland, Florida (1.2 mi)
· Sponsor: Jazz Pharmaceuticals
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Brandon, Florida (21.8 mi)
· Sponsor: Ambros Therapeutics, Inc.
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Brandon, Florida (21.8 mi)
· Sponsor: Hoffmann-La Roche
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Bay Area Cardiology — Brandon, Florida (21.8 mi)
· Sponsor: Boehringer Ingelheim
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 2
Interventional 405 participants sought
Meris Clinical Research-Brandon-69466 — Brandon, Florida (21.8 mi)
· Sponsor: Boehringer Ingelheim
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma
Phase 2
Interventional 86 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Bay Area Cardiology — Brandon, Florida (21.8 mi)
· Sponsor: Boehringer Ingelheim
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50239 — Brandon, Florida (21.8 mi)
· Sponsor: UCB Biopharma SRL
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
Phase 1, Phase 2
Interventional 37 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Florida Retina Consultants — Lakeland, Florida (1.2 mi)
· Sponsor: EyeBiotech Ltd.
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
The Watson Clinic — Lakeland, Florida (1.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Accel Research Sites - Lakeland Clinical Research Unit — Lakeland, Florida (1.2 mi)
· Sponsor: Eli Lilly and Company
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Accel Research Sites - Lakeland Clinical Research Unit — Lakeland, Florida (1.2 mi)
· Sponsor: Eli Lilly and Company